BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7514553)

  • 41. Levels of total alpha-macroglobulin and trypsin-like immunoreactivity are poor indicators of clinical severity in spontaneous canine acute pancreatitis.
    Ruaux CG; Atwell RB
    Res Vet Sci; 1999 Aug; 67(1):83-7. PubMed ID: 10425245
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Therapeutic effects of human urinary trypsin inhibitor on acute experimental pancreatitis].
    Ohnishi H; Kosuzume H; Ashida Y; Kato K; Suzuki Y; Honjo I
    Nihon Yakurigaku Zasshi; 1983 Mar; 81(3):235-44. PubMed ID: 6345304
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The elimination of trypsin--alpha-macroglobulin complexes from the blood circulation in pigs during acute pancreatitis and after massive intravenous trypsin infusion.
    Sjölund B; Lasson A; Ohlsson K
    Scand J Clin Lab Invest; 1987 Apr; 47(2):131-41. PubMed ID: 2437645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of the protease-antiprotease balance in peritoneal exudate during acute pancreatitis.
    Wilson C; Shenkin A; Imrie C
    Br J Surg; 1991 Jan; 78(1):78-81. PubMed ID: 1705461
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of octreotide pretreatment in experimental acute pancreatitis.
    Salem MZ; Cunha JE; Coelho AM; Sampietri SN; Machado MC; Penteado S; Abdo EE
    Pancreatology; 2003; 3(2):164-8. PubMed ID: 12748426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Changes in blood enzyme activity and tumor necrosis factor level in the treatment of experimental pancreatitis with pentoxifylline].
    Zaporozhchenko BS
    Klin Khir; 1998; (3):13-4. PubMed ID: 9670713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular forms of immunoreactive pancreatic cationic trypsin in pancreatitis patient sera.
    Brodrick JW; Geokas MC; Largman C; Fassett M; Johnson JH
    Am J Physiol; 1979 Nov; 237(5):E474-80. PubMed ID: 91323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cimetidine treatment in acute experimental pancreatitis.
    Evander A; Ihse I
    Eur Surg Res; 1980; 12(5):301-9. PubMed ID: 6163633
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protein proteinase inhibitor therapy in experimental pancreatitis: pharmacological characterization of the inhibitor.
    Valueva TA; Matveev NL; Mosolov VV; Penin VA
    Agents Actions Suppl; 1992; 38 ( Pt 2)():203-10. PubMed ID: 1462828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Interaction of proteases and their inhibitors in the pathogenesis of pancreatitis].
    Takasugi S; Kanao M; Nishiki M; Dohi K; Ezaki H
    Nihon Geka Gakkai Zasshi; 1985 Sep; 86(9):1245-8. PubMed ID: 2418345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proteases and protease inhibitors in taurocholate-induced acute pancreatitis in rats.
    Kruse P; Hage E; Lasson A
    Int J Pancreatol; 1999 Apr; 25(2):113-21. PubMed ID: 10360224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma alpha 2-macroglobulin-trypsin complexlike substance (MTLS) in pancreatic disease.
    Kato M; Hayakawa S; Naruse S; Kitagawa M; Nakae Y; Hayakawa T
    J Clin Lab Anal; 1996; 10(6):399-402. PubMed ID: 8951609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Removal of trypsin complexed alpha-2 macroglobulin by plasma fractionation.
    Nakayama S; Hermann RE; Malchesky PS; Zborowski M; Walsh RM; Sato T
    ASAIO J; 1993; 39(3):M297-300. PubMed ID: 7505639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of protease inhibitors on the activity of trypsin and lipase in the pancreas and blood serum of rats in acute pancreatitis].
    Khudoley IF; Levitsky AP; Synovets AS
    Vopr Med Khim; 1975; 21(3):296-9. PubMed ID: 1210107
    [No Abstract]   [Full Text] [Related]  

  • 55. Proteinase inhibition in plasma during experimental acute rat pancreatitis.
    Huttunen R
    Ann Med Exp Biol Fenn; 1973; 51(4):139-44. PubMed ID: 4787807
    [No Abstract]   [Full Text] [Related]  

  • 56. Ghrelin attenuates the development of acute pancreatitis in rat.
    Dembinski A; Warzecha Z; Ceranowicz P; Tomaszewska R; Stachura J; Konturek SJ; Konturek PC
    J Physiol Pharmacol; 2003 Dec; 54(4):561-73. PubMed ID: 14726611
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of mast-cell stabilization in cerulein-induced acute pancreatitis in rats.
    Yönetçi N; Oruç N; Ozütemiz AO; Celik HA; Yüce G
    Int J Pancreatol; 2001; 29(3):163-71. PubMed ID: 12067220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunoreactive forms of cationic trypsin in plasma and ascitic fluid of dogs in experimental pancreatitis.
    Geokas MC; Largman C; Durie PR; Brodrick JW; Ray SB; O'Rourke M; Vollmer J
    Am J Pathol; 1981 Oct; 105(1):31-9. PubMed ID: 6170231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo imaging with fluorescent smart probes to assess treatment strategies for acute pancreatitis.
    Agarwal A; Boettcher A; Kneuer R; Sari-Sarraf F; Donovan A; Woelcke J; Simic O; Brandl T; Krucker T
    PLoS One; 2013; 8(2):e55959. PubMed ID: 23409095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The Pancreas Study Group: Inhibition of pancreas secretion and trypsin activity. Mechanisms and importance of therapy of acute and chronic pancreatitis].
    Z Gastroenterol Verh; 1987 Apr; 22():132-55. PubMed ID: 2442904
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.